지난 1월 4일(토) 개최되었던 본 학회 제4차 골대사질환 심화과정에서 ASBMR highlight 소개된 사항이 ASBMR에 e-News Letter를 통해 골대사연구자분들께 안내가 되었습니다.  
|
|
|
|
| | |  | Takeda Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) will continue its recall of NATPARA® for the treatment of hypoparathyroidism indefinitely in the United States. The reason for the recall is the observation of some tiny but visible rubber particles in the NATPARA® solution. These particles originate from the rubber septum of the cartridge, which is punctured by the replaceable cartridge needle each time an injection is made. When the septum is repeatedly pierced, small pieces of rubber may detach into the solution. The recall has created a major disruption in the care of patients in the U.S. In September 2019, the ASBMR and the Endocrine Society issued joint guidance on transitioning hypoparathyroidism patients from NATPARA®. |
|
 | ASBMR webinars are a popular member benefit that allow for easy access year-around to high-quality, relevant educational content through the ASBMR Education Resource Center. For 2020, we’ve assembled a webinar program featuring diverse musculoskeletal topics in clinical, basic and translational research, clinical practice, as well as professional development. View the ASBMR 2020 Webinar Schedule now! |
|
 | The musculoskeletal field (as other medical fields) is experiencing an unprecedented buoyant period of genetic discoveries arising from Genome-Wide Association and Sequencing (whole exome and whole-genome) Studies. JBMR® welcomes new papers on the biological validation of genes and/or variants identified through GWAS or Sequencing Studies that can help elucidate disease risk in the bone and mineral field. Please submit your original research or short reviews by June 1st, 2020. Short reviews on the following topics are encouraged: • Variant and gene prioritization • Functional assessment of regulatory regions • Chromatin conformation analyses • New methods and techniques Please visit the ASBMR page at Wiley for more information. |
|
 | Applications are now being accepted for the 2020 Phoebe Leboy Professional Development Award. This award is for a female young investigator who resides outside the United States (preference given to those in an emerging or developing country). The award provides monetary resources for the selected individual to attend the 2020 ASBMR Annual Meeting, membership in ASBMR, and mentorship from female senior investigators in related areas of research. The award amount is up to $2,000 USD. To read more about the award and eligibility requirements, click here. Applicants must submit a draft of the abstract they plan to present at the 2020 ASBMR Annual Meeting, one letter of support, a current CV, and a summary of their career objectives. The application deadline is Friday, February 14, 2020. |
|
 | ASBMR is now accepting nominations for the 2020 Fellows of the ASBMR. This distinguished program recognizes long-term ASBMR members who have made outstanding contributions to the field of bone, mineral and musculoskeletal science. To be considered eligible, one must: - Be a current Full Member or Emeritus Member of ASBMR
- Have been a Full Member of ASBMR for at least 10 years (does not have to be continuous)
- Have demonstrated significant contributions to the field
- Have published at least five articles in JBMR® and/or JBMR® Plus (including Annual Meeting abstracts)
The program is committed to recognizing the breadth and diversity of the Society’s membership. Fellows are nominated by their peers, followed by evaluation and selection by a review committee. To learn more about this program and review the nomination guidelines, click here. The nomination deadline is March 13, 2020. |
|
 | | Many Thanks goes to ASBMR Ambassador Yumie Rhee, M.D., Ph.D. who facilitated the presentation of the ASBMR 2019 Annual Meeting Highlights at the 4th Bone Specialist Program of the Korean Society of Bone and Mineral Research (KSBMR) on January 4, 2020 in Seoul, South Korea. The highlights were presented by former KSBMR President Dong-Won Byun, M.D., Ph.D. and Professor Je-Yong Choi of Kyungpook University. By sharing the ASBMR Annual Meeting highlights, over 150 attendees had the opportunity to obtain an overview of the ASBMR Annual Meeting and learn more about the latest cutting-edge science in bone and mineral research. |
|
 | The 8 th International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems is now accepting abstracts and applications for travel awards. The conference is co-sponsored by ASBMR and will take place in Ioannina, Greece, July 7-14, 2020. The deadline to submit an abstract and apply for a travel award is March 15, 2020. The bi-annual International Conference on Osteoimmunology is the only international conference that focuses solely on interactions of the bone and the immune system. For more information on this year’s event, please click here. |
|
 | The Global Fragility Fracture Network (FFN) is calling for submissions of proposals to host a workshop at the 2020 Congress in Toronto, September 24-26, 2020. The deadline to submit a workshop proposal is January 31, 2020. For more information on the proposal submission process and the 2020 Congress please click here. The FFN Congress meets each year to bring together individuals who have an interest in the management of fragility fractures with a focus on implementation of evidence-based medicine to improve access and care for patients. |
|
| The January issue of JBMR is now online! History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55–90 Years Presenting with a Fragility Fracture
Emese Toth MSc, Jonas Banefelt MSc, Kristina åkesson MD PhD, Anna Spångeus MD PhD, Gustaf Ortsäter MSc, Cesar Libanati MD
First Published: 08 January 2020
BMP9 reduces bone loss in ovariectomized mice by dual regulation of bone remodeling
Yan‐man Zhou MS, Yu‐ying Yang BS, Yi‐xuan Jing MS, Tian‐jiao Yuan BS, Li‐hao Sun PhD, Bei Tao PhD, Jian‐min Liu PhD, Hong‐yan Zhao PhD
First Published: 08 January 2020 |
|
Short‐term glucocorticoid treatment reduces circulating sclerostin concentrations in healthy young men: a randomized, placebo‐controlled, double‐blind study
Merel Jacobsson MD, Daniël H. van Raalte MD, PhD, Annemieke C. Heijboer MD, PhD, Martin den Heijer MD, PhD, Renate T. de Jongh MD, PhD
First Published: 16 January 2020 |
|
| Career Opportunities in Bone |
|
|
|
| | |
|
